AKESO BIOPHARMA
The company has built a global level of bio-pharmaceutical research and development and industrialization platform; established for cancer, autoimmune diseases, inflammation and cardiovascular disease of the rich product line. The scale of the company's platform, hardware and software facilities, the number of new drug product lines, R & D team in the country are the same industry-leading level. Kang Fang biological has been with the international and domestic listed pharmaceutical companies to establish a cooperative relationship, the joint development of innovative antibodies to new drugs, is a strategic cooperation in the form of development of new drugs in the forerunner.
AKESO BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2012-01-01
Address:
Zhongshan, Anhui, China
Country:
China
Website Url:
http://www.akesobio.com
Total Employee:
101+
Status:
Active
Contact:
0760-8987 3998
Email Addresses:
[email protected]
Total Funding:
219.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Euro
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Ark Biosciences
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development
Dare Bioscience
Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.
Duality Biologics
Duality Biologics is a company focusing on the discovery, development and commercialization of new modality biologics to provide solutions.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Entera Bio
Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel drug delivery platform.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Idorsia
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
InspireMD
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
resTORbio
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
STELLA PHARMA
Stella Pharma is a company that aims to contribute to medical care through the development of prescription drugs.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Employees Featured
Founder
Stock Details
Investors List
BOCOM International
BOCOM International investment in Series D - Akeso Biopharma
OrbiMed
OrbiMed investment in Series D - Akeso Biopharma
Loyal Valley Capital
Loyal Valley Capital investment in Series D - Akeso Biopharma
Apricot Capital
Apricot Capital investment in Series D - Akeso Biopharma
CDG International Company
CDG International Company investment in Series D - Akeso Biopharma
K. Wah Group
K. Wah Group investment in Series D - Akeso Biopharma
AIHC Capital
AIHC Capital investment in Series D - Akeso Biopharma
Shenzhen Capital Group
Shenzhen Capital Group investment in Series D - Akeso Biopharma
Lake Bleu Capital
Lake Bleu Capital investment in Series D - Akeso Biopharma
Sino Biopharmaceutical
Sino Biopharmaceutical investment in Series D - Akeso Biopharma
Official Site Inspections
http://www.akesobio.com Semrush global rank: 2.65 M Semrush visits lastest month: 6.42 K
- Host name: 42.159.132.179
- IP address: 42.159.132.179
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
